Dr. Ryan Glen Smith, MD

Dr. Smith practices at Dignity Health Medical Group - Sierra Nevada, a Service of Dignity Hea in Grass Valley, California.

Dr. Smith's NPI, 1639197452, was assigned on July 18, 2006. Dr. Smith graduated from University of California, San Francisco School of Medicine in 2004. Dr. Smith holds California license A74197.

Dr. Smith's primary practice is Dignity Health Medical Group - Sierra Nevada, a Service of Dignity Hea, at 280 Sierra College Dr, Grass Valley, CA 95945 in Nevada County. The practice phone is (530) 274-6727.

Dr. Smith's primary practice is Dignity Health Medical Group - Sierra Nevada, a Service of Dignity Hea in Grass Valley, California. Dr. Smith is also affiliated with Dignity Health - Sierra Nevada Memorial Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Smith to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Smith is licensed in California.

CMS data shows 4,259 Medicare services from Dr. Smith across 39 procedure codes in 2024, for 1,378 Medicare patients. Medicare paid $205,314 for them.

CMS counts 1,378 Medicare patients who saw Dr. Smith in 2024. The largest group is 75 to 84, with 581 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 68, with 56% women.

In 2024, Dr. Smith wrote 5,683 Medicare Part D claims for 651 patients. 83% of them were for generic drugs. CMS names the drug for 5,399 of them, across 57 drugs with 11 or more claims each, at $887,473 in total drug cost. In 2023, CMS named 4,908 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Smith for performance year 2024, reported through an alternative payment model (APM). Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith as offering telehealth.

CMS Open Payments shows 81 general payments to Dr. Smith from 14 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 60% of the total. Biotronik Inc. paid the most, $3,493.

Dr. Smith graduated from University of California, San Francisco School of Medicine in 2004.